Priorix - Powder and solvent for solution for injection in a pre-filled syringeMeasles, Mumps and Rubella vaccine (live) Ireland - English - HPRA (Health Products Regulatory Authority)

priorix - powder and solvent for solution for injection in a pre-filled syringemeasles, mumps and rubella vaccine (live)

glaxosmithkline (ireland) limited - measles virus - schwarz strain live attenuated; mumps vaccine rit 4385 live attenuated; rubella virus (ra 27/3 strain) - powder and solvent for solution for injection in pre-filled syringe - 0 percent - measles vaccines; measles, combinations with mumps and rubella, live attenuated

IPOL (poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus United States - English - NLM (National Library of Medicine)

ipol (poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus

sanofi pasteur inc. - poliovirus type 1 antigen (formaldehyde inactivated) (unii: 0lvy784c09) (poliovirus type 1 antigen (formaldehyde inactivated) - unii:0lvy784c09), poliovirus type 2 antigen (formaldehyde inactivated) (unii: 23je9kdf4r) (poliovirus type 2 antigen (formaldehyde inactivated) - unii:23je9kdf4r), poliovirus type 3 antigen (formaldehyde inactivated) (unii: 459rom8m9m) (poliovirus type 3 antigen (formaldehyde inactivated) - unii:459rom8m9m) - poliovirus type 1 antigen (formaldehyde inactivated) 40 [d'ag'u] in 0.5 ml - ipol vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus types 1, 2, and 3. (28) it is recommended that all infants (as young as 6 weeks of age), unimmunized children, and adolescents not previously immunized be vaccinated routinely against paralytic poliomyelitis. (29) following the eradication of poliomyelitis caused by wild poliovirus from the western hemisphere (including north and south america) (30), an ipv-only schedule was recommended to eliminate vapp. (7) all children should receive four doses of ipv at ages 2, 4, 6 to 18 months, and 4 to 6 years. opv is no longer available in the us and is not recommended for routine immunization. (7) previous clinical poliomyelitis (usually due to only a single poliovirus type) or incomplete immunization with opv are not contraindications to completing the primary series of immunization with ipol vaccine. children of all ages should have their immuni

PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial with prefilled diluent syringe Australia - English - Department of Health (Therapeutic Goods Administration)

proquad measles, mumps, rubella, varicella live virus vaccine injection vial with prefilled diluent syringe

merck sharp & dohme (australia) pty ltd - measles virus, quantity: 3 tcid50; mumps virus, quantity: 4.3 tcid50; rubella virus, quantity: 3 tcid50; live varicella vaccine, quantity: 3.99 pfu - injection, powder for - excipient ingredients: potassium chloride; hydrolysed gelatin; urea; neomycin; sodium bicarbonate; albumin; sodium chloride; sucrose; monobasic sodium phosphate; dibasic sodium phosphate; phenolsulfonphthalein; monosodium glutamate monohydrate; monobasic potassium phosphate; dibasic potassium phosphate; sorbitol; glucose monohydrate; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; water for injections; polysorbate 80; ascorbic acid; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; - proquad is indicated for simultaneous immunisation against measles, mumps, rubella and varicella in individuals 12 months through 12 years of age.

PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

proquad measles, mumps, rubella, varicella live virus vaccine injection vial

merck sharp & dohme (australia) pty ltd - measles virus, quantity: 3 tcid50; rubella virus, quantity: 3 tcid50; mumps virus, quantity: 4.3 tcid50; live varicella vaccine, quantity: 3.99 pfu - injection, powder for - excipient ingredients: monobasic sodium phosphate; sodium bicarbonate; albumin; hydrolysed gelatin; sucrose; phenolsulfonphthalein; monobasic potassium phosphate; neomycin; potassium chloride; urea; sorbitol; dibasic potassium phosphate; monosodium glutamate monohydrate; sodium chloride; dibasic sodium phosphate; glucose monohydrate; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; water for injections; polysorbate 80; ascorbic acid; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; - proquad is indicated for simultaneous immunisation against measles, mumps, rubella and varicella in individuals 12 months through 12 years of age.

VIRAL IMMUNE STIMULATOR 6017- viral immune stimulator liquid United States - English - NLM (National Library of Medicine)

viral immune stimulator 6017- viral immune stimulator liquid

professional complementary health formulas - aqua marina 3x asclepias tuberosa 3x trifolium pratense 3x echinacea purpurea 3x euphrasia officinalis 6x lac vaccinum 6x thuja occidentalis 6x, 12x, 30x ferrum iodatum 8x camphora 12x calcarea arsenicica 12x ichthyolum 12x vaccinotoxinum 30x, 60x morbillinum 30x, 60x variolinum 30x, 60x influenzinum 30x, 60x vincetoxicum 30x, 60x coxsackievirus 30x, 60x encephalitis 30x, 60x bcg 30x, 60x cytomegalovirus 30x, 60x - temporarily relieves runny nose, chills, sweats, sore throat, minor aches and pains in the muscles or joints, or occasional headache.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

CHILDHOOD DISEASES NOSODE COMBINATION 9408- childhood diseases nosode combination liquid United States - English - NLM (National Library of Medicine)

childhood diseases nosode combination 9408- childhood diseases nosode combination liquid

professional complementary health formulas - belladonna 3x chamomilla 3x gelsemium sempervirens 3x dulcamara 4x pulsatilla 4x calcarea carbonica 8x morbillinum 12x parotitis 12x rubella 12x varicella 12x - for the temporary relief of occasional headache, fatigue, cough, runny nose, or minor sore throat.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

M-M-R II- measles, mumps, and rubella virus vaccine live injection, powder, lyophilized, for suspension United States - English - NLM (National Library of Medicine)

m-m-r ii- measles, mumps, and rubella virus vaccine live injection, powder, lyophilized, for suspension

a-s medication solutions - measles virus strain enders' attenuated edmonston live antigen (unii: mfz8i7277d) (measles virus strain enders' attenuated edmonston live antigen - unii:mfz8i7277d), mumps virus strain b level jeryl lynn live antigen (unii: 47qb6mx9ku) (mumps virus strain b level jeryl lynn live antigen - unii:47qb6mx9ku), rubella virus strain wistar ra 27/3 live antigen (unii: 52202h034z) (rubella virus strain wistar ra 27/3 live antigen - unii:52202h034z) - m-m-r® ii is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. do not administer m-m-r ii vaccine to individuals with a history of hypersensitivity to any component of the vaccine (including gelatin) {3} or who have experienced a hypersensitivity reaction following administration of a previous dose of m-m-r ii vaccine or any other measles, mumps and rubella-containing vaccine. do not administer m-m-r ii vaccine to individuals with a history of anaphylaxis to neomycin [see description (11)]. do not administer m-m-r ii vaccine to individuals who are immunodeficient or immunosuppressed due to disease or medical therapy. measles inclusion body encephalitis {4} (mibe), pneumonitis {5} and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine. in this population, disseminated mumps and rubella vacc

Priorix Pdr+Solv for Soln for Inj - Measles Mumps and Rubella vaccine (live) Malta - English - Medicines Authority

priorix pdr+solv for soln for inj - measles mumps and rubella vaccine (live)

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - mumps vaccine, rit, measles virus, schwarz strain, rubella virus, wistar ra - powder and solvent for solution for injection - measles virus - schwarz strain rubella virus - wistar ra27/3 strain mumps vaccine rit 4385 - vaccines

Measles Vaccine Live Attenuated (Freeze-Dried) Injection Kenya - English - Pharmacy and Poisons Board

measles vaccine live attenuated (freeze-dried) injection

serum institute of india ltd. 212/2 hadapsar pune 411028 india - measles vaccine live attenuated (freeze-dried) - injection - each single human dose when reconstituted in a… - viral vaccines: measlesvaccines